Randomized trial of treatment of amblyopia in children aged 7 to 17 years

Mitchell M Scheiman1, Richard W Hertle, Roy W Beck

  • 1Jaeb Center for Health Research, Tampa, FL 33647, USA. pedig@jaeb.org

Insights

Patching and atropine significantly improved vision in younger children (7-12) with amblyopia. Older adolescents (13-17) showed benefits only if previously untreated, highlighting age-specific amblyopia treatment effectiveness.

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Vision Science

Background:

  • Amblyopia, or "lazy eye," affects visual development in children.
  • Effective treatment strategies for older children and adolescents remain an area of research.

Purpose of the Study:

  • To assess the efficacy of amblyopia treatment in children aged 7 to 17 years.
  • To compare combined patching and atropine therapy with optical correction alone.

Main Methods:

  • 507 patients with amblyopia (visual acuity 20/40 to 20/400) received optical correction.
  • Randomization to either a treatment group (patching, near activities, atropine for younger) or optical correction alone.
  • Response defined as a ≥2-line improvement in visual acuity by 24 weeks.

Main Results:

  • In 7-12 year olds, 53% of the treatment group responded vs. 25% in the control group (P<.001).
  • In 13-17 year olds, overall response rates were similar (25% vs. 23%), but higher in the treatment group if previously untreated (47% vs. 20%, P=.03).
  • Most patients retained some visual deficit post-treatment.

Conclusions:

  • Optical correction alone improves amblyopia in about 25% of patients aged 7-17.
  • Combined therapy is effective for 7-12 year olds, even with prior treatment.
  • For 13-17 year olds, treatment is beneficial for previously untreated cases; long-term outcomes require further study.
Abstract

Related Concept Videos